CROCKER GARY L 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Aug 14, 2023
Insider Transaction Report
Form 4
CROCKER GARY L
Director
Transactions
- Purchase
Common Stock
2023-08-11$12.43/sh+2,000$24,865→ 133,105 total(indirect: See footnote) - Purchase
Common Stock
2023-08-10$12.52/sh+2,000$25,039→ 133,105 total(indirect: See footnote)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.48 to $12.54, inclusive on August 10, 2023. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]Shares held by Crocker Family Investments, LLC, over which Reporting Person is the Managing Member.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.38 to $12.50, inclusive on August 11, 2023. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.